Yabao Pharmaceutical Group Co., Ltd (SHA:600351)
China · Delayed Price · Currency is CNY 6.86
+0.09 (1.33%)
Feb 4, 2026, 3:00 PM CST
SHA:600351 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 222.85 | 242.69 | 199.59 | 104.66 | 187.09 | 107.37 |
Depreciation & Amortization | 140.13 | 140.13 | 159.2 | 163.83 | 171.06 | 169.88 |
Other Amortization | 0.95 | 0.95 | 0.49 | 0.56 | 1.18 | 0.92 |
Loss (Gain) From Sale of Assets | -0.35 | -0.35 | -1.12 | -0.12 | -0.15 | -2.63 |
Asset Writedown & Restructuring Costs | 27.53 | 27.53 | 84.94 | 58.05 | 22.97 | 3.44 |
Loss (Gain) From Sale of Investments | 3.04 | 3.04 | 5.35 | 4.17 | -14.87 | -3.34 |
Provision & Write-off of Bad Debts | 1.42 | 1.42 | -4.83 | 0.53 | -13.56 | -2.14 |
Other Operating Activities | 93.02 | -1.06 | 5.49 | 37.33 | 31.71 | 44.3 |
Change in Accounts Receivable | 93.27 | 93.27 | 69.27 | -6.95 | 49.92 | 137.8 |
Change in Inventory | 11 | 11 | -2.52 | 61.03 | -32.41 | 60.23 |
Change in Accounts Payable | -36.2 | -36.2 | -22.41 | 44.91 | 42.9 | -134.11 |
Change in Other Net Operating Assets | - | - | - | - | - | -0.11 |
Operating Cash Flow | 545.94 | 471.69 | 497.55 | 460.46 | 437.5 | 380.96 |
Operating Cash Flow Growth | 0.09% | -5.20% | 8.05% | 5.25% | 14.84% | -10.40% |
Capital Expenditures | -45.11 | -34.66 | -99.86 | -62.23 | -95.05 | -62.87 |
Sale of Property, Plant & Equipment | 0.22 | 0.9 | 14.59 | 1.25 | 1.14 | 4.22 |
Cash Acquisitions | - | -0.01 | - | - | - | -8.06 |
Investment in Securities | 3.47 | -2.36 | -42.51 | -40.87 | -36.98 | -148.51 |
Other Investing Activities | 1.99 | 2.48 | 0.4 | 5.12 | 5.53 | 5.69 |
Investing Cash Flow | -39.43 | -33.65 | -127.37 | -96.73 | -125.37 | -209.52 |
Long-Term Debt Issued | - | 90 | 348.6 | 619.53 | 521.49 | 839 |
Long-Term Debt Repaid | - | -206.68 | -593.64 | -712.6 | -647.71 | -1,110 |
Net Debt Issued (Repaid) | 5.32 | -116.68 | -245.04 | -93.07 | -126.22 | -271.18 |
Repurchase of Common Stock | -237.74 | -237.74 | -150.45 | - | - | - |
Common Dividends Paid | -210.71 | -113.57 | -51.26 | -81.61 | -60.4 | -49.5 |
Other Financing Activities | 30.96 | 42.72 | - | -3.95 | - | 5.89 |
Financing Cash Flow | -412.17 | -425.27 | -446.75 | -178.64 | -186.62 | -314.78 |
Foreign Exchange Rate Adjustments | 0.02 | 0.02 | 0.01 | 0.22 | -0.05 | 0.14 |
Net Cash Flow | 94.35 | 12.79 | -76.56 | 185.32 | 125.46 | -143.21 |
Free Cash Flow | 500.83 | 437.03 | 397.7 | 398.23 | 342.45 | 318.09 |
Free Cash Flow Growth | 0.70% | 9.89% | -0.13% | 16.29% | 7.66% | 18.66% |
Free Cash Flow Margin | 22.03% | 16.27% | 13.67% | 14.65% | 12.39% | 12.22% |
Free Cash Flow Per Share | 0.71 | 0.60 | 0.52 | 0.52 | 0.45 | 0.41 |
Cash Income Tax Paid | 255.54 | 286.73 | 286.02 | 219.58 | 234.67 | 308 |
Levered Free Cash Flow | 425.26 | 339.33 | 358.48 | 343.87 | 272.62 | 262.63 |
Unlevered Free Cash Flow | 426.38 | 342.67 | 366.17 | 355.6 | 286.75 | 283.01 |
Change in Working Capital | 57.35 | 57.35 | 48.44 | 91.45 | 52.07 | 63.15 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.